换一批Comparison between patients with Philadelphia-positive chronic phase chronic myeloid leukemia who obtained a complete cytogenetic response within 1 year of imatinib therapy and those who achieved such a response after 12 months of treatment.
第一作者：
Ilaria,Iacobucci
第一单位：
Institute of Hematology and Medical Oncology "Seràgnoli", University of Bologna, Bologna, Italy.
作者：
医学主题词
成年人(Adult);老年人(Aged);抗肿瘤药(Antineoplastic Agents);苯甲酰胺类(Benzamides);无病生存(Disease-Free Survival);女(雌)性(Female);融合蛋白质类, bcr-abl(Fusion Proteins, bcr-abl);人类(Humans);白血病, 髓系, 慢性, BCR-ABL阳性(Leukemia, Myelogenous, Chronic, BCR-ABL Positive);白血病, 髓样, 慢性期(Leukemia, Myeloid, Chronic-Phase);男(雄)性(Male);中年人(Middle Aged);哌嗪类(Piperazines);蛋白激酶抑制剂(Protein Kinase Inhibitors);蛋白酪氨酸激酶类(Protein-Tyrosine Kinases);嘧啶类(Pyrimidines);回顾性研究(Retrospective Studies);存活率分析(Survival Analysis);时间因素(Time Factors);治疗结果(Treatment Outcome)
DOI
10.1200/JCO.2005.03.2011
PMID
16421422
发布时间
2015-11-19
- 浏览30
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
